Dr. Ami Appleboom, Chairman of the Innovation Authority and Chief Scientist at the Ministry of Economy and Industry, on the companies PixCell Medical and CorNeat Vision as winners of the most innovative startup competition in the field of life sciences. The PixCell Medical company developed a breakthrough technology for performing live cell diagnostics using a single finger prick blood test and the CorNeat Vision company developed an artificial cornea. The announcement of the winners took place as part of a competition led by the Innovation Authority at the MIXiii Biomed 2018 event, the annual event of the life sciences industry
Dr. Ami Appleboom, Chairman of the Innovation Authority and Chief Scientist at the Ministry of Economy and Industry, announced at the closing session of the conference that PixCell Medical, which developed a groundbreaking technology for performing live cell diagnostics using a single finger prick blood test, and CorNeat Vision, which developed an artificial cornea, as the winners of the competition. The most innovative start-up in the field of life sciences.
The announcement of the winners took place as part of a start-up competition dedicated to companies offering groundbreaking developments in the field of life sciences, which was led by the Innovation Authority at the MIXiii Biomed 2018 event, the annual event of the life sciences industry, which focused this year on the trends shaping the future of healthcare and life sciences systems. Among the dozens of candidates who submitted the application, 45 companies were selected to exhibit in the unique start-up complex established under the leadership of the Innovation Authority as part of the exhibition. Of these, 10 companies were able to participate in the conference's startup competition, in which they presented their groundbreaking technology to the participants.
PixCell Medical has developed a breakthrough technology for performing blood tests in the doctor's office without the need to transfer them to a laboratory. HemoScreen is a portable, small and easy-to-use device that performs a complete blood count in 5 minutes using a disposable cartridge. Only one drop of blood taken from a finger prick is needed to perform the test. In addition, the system allows a diagnosis between 5 different types of white blood cells as well as the identification of abnormal cells indicating various pathologies. The device does not require maintenance or calibration and therefore can be operated by any user and without the need for a laboratory infrastructure. The technology is based on three innovative principles: Viscoelastic Focusing, a new physical phenomenon discovered at the Technion, which causes cells to focus during flow and enables their analysis. A disposable cartridge that prepares the blood sample automatically and advanced algorithms of computer vision and artificial intelligence to analyze the cell images. The product will enable the provision of faster and better quality treatment in a variety of treatment points such as oncology, intensive care and general practitioners while significantly streamlining the treatment process.
CorNeat Vision develops an artificial corneal implant. The innovation in the CorNeat implant is the ability to anchor a synthetic lens to the eye using only artificial materials. This implant is built from a central optical part and an integrative element that is responsible for a long-term connection with the wall of the eye. The innovation in the implant is in the anchoring point in the wall of the eye and in the material of the biointegrative element. The company promotes a "synthetic biology" platform that enables the assimilation of various synthetic components into biological tissue with an emphasis on the eye and the eye socket.
The other companies that participated in the competition are (more information about each of the companies appears later in the announcement): Alpha Tau Medical, which developed targeted alpha radiation to damage cancerous tumors; Neurosteer, which developed a sensor that monitors the brain's electrical activity and provides high-level biomarkers; NovaSight - diagnosis of strabismus and vision problems in children by watching a video; Brainvivo which offers early detection and diagnosis of brain diseases; The TempraMed company has developed a series of products that make it possible to maintain a constant temperature for medicines; E-Motion Medical Ltd restore the function of the digestive system; BarimOte provides a real-time response to gastric bypass surgeries through sensor implantation and SpacePharma, which promotes research in zero gravity conditions.
The judging committee that chose the winners of the competition was made up of senior officials in the life sciences industry in Israel: Ami Applebaum, Chairman of the News Authority and Chief Scientist at the Ministry of Economy and Industry, Anya Eldan, Vice President of the Innovation Authority and Head of the Startup Arena, Karin Meyer-Robinstein, CEO of IATI, Yaki Yanai, Co-Chairman and Head of Life Sciences at IATI and Dr. Irit Yaniv, a partner in the Excelmed Foundation.
Ami Appleboom, Chairman of the News Authority and Chief Scientist at the Ministry of Economy and Industry: "This competition was a microcosm for Israeli innovation in all its glory. The 10 companies that presented to us were impressive in their quality and innovation and the choice was indeed difficult. From micro-organisms to space technologies, we were presented with the best innovations of biomed startups. The winning companies PixCell Medical and CorNeat Vision demonstrated unique technologies and a solid global activity strategy, and are an example and model of excellence designed to improve the lives of people wherever they are.'
Ruthi Alon, CEO and founder of Medstrada and co-chair of the MIXiii Biomed conference: "The startup competition of the MIXiii Biomed 2018 event serves as a springboard for leading companies in the field of life sciences. We welcome the opportunity to help companies break into the market and expose them for the benefit of alliances and collaborations that will provide solutions that will benefit all of humanity."